Related Experiment Video
Updated: Aug 24, 2026

Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing
Published on: June 9, 2017
Molecular basis of bilirubin-induced neurotoxicity
J Donald Ostrow1, Lorella Pascolo, Dora Brites
1Research Service, VA Puget Sound Health Care System-Seattle Division, and GI/Hepatology Division, Department of Medicine, University of Washington School of Medicine, Seattle, WA 98108-1597, USA.
Abstract:
Unconjugated bilirubin (UCB), at slightly elevated unbound concentrations, is toxic to astrocytes and neurons, damaging mitochondria (causing impaired energy metabolism and apoptosis) and plasma membranes (causing oxidative damage and disrupting transport of neurotransmitters). Accumulation of UCB in the CSF and CNS is limited by its active export, probably mediated by MRP1/Mrp1 present in choroid plexus epithelia, capillary endothelia, astrocytes and neurons. Upregulation of MRP1/Mrp1 protein levels by UCB might represent an important adaptive mechanism that protects the CNS from UCB toxicity. These concepts could explain the varied susceptibility of newborns to bilirubin neurotoxicity and the occurrence of neurological damage at plasma UCB concentrations well below therapeutic guidelines, and are relevant to the increasing prevalence of bilirubin encephalopathy in newborns.
Related Concept Videos
Hepatic Encephalopathy
Jaundice
Bioactivation and Tissue Toxicity
The Blood-brain Barrier

